Skip to main content
. 2016 Jul 29;7(37):59781–59794. doi: 10.18632/oncotarget.10926

Figure 3. Determination of possible cross resistances of enzalutamide resistant cell lines with abiraterone or bicalutamide.

Figure 3

Proliferation A. and viability B. in DuCaP, LAPC4 and LNCaP Abl vehicle and enzalutamide resistant cell lines after 6 days of exposure to 8 μM abiraterone or 10 μM bicalutamide was measured by 3[H]thymidine incorporation assay and WST assay, respectively. Ethanol was used as control. Data represent mean +SEM from at least 3 independent experiments. *;p=<0.05. **;p=<0.01. ***;p=<0.001